Signup · Epionce
  • Our Approach
  • Products
  • Our Story
  • Why a Skin Care Professional
  • The Magazine
Signup ›
  • What's New

  • 20% Off Flash Sale Learn More >

    20% Off Flash Sale

  • Dr. Carl's Story Read Now >

    Dr. Carl's Story
  • Epionce Near You   Nearby  
  • Login
20% Off Flash Sale Dr. Carl's Story
Epionce Logo Epionce Logo
  • 0

  • 20% Off Flash Sale Learn More >

    Dr. Carl's Story Read Now >

  • Epionce Near You  
  • Login

    No Account? Signup ›

  • Our Approach
  • Products
  • Our Story
  • Why a Skin Care Professional
  • The Magazine

Signup

Already have an account? Login.

Don't have a Professional?

You may qualify for FREE shipping!
Connect with a Professional Near You.

Find Nearby Professionals

Required Field




Choose your web browser from below:

  • Chrome
  • Firefox
  • Safari
  • Internet Explorer
  • Microsoft Edge
  • Opera

  • Dr. Carl
  • Returns
  • Shipping Policy
  • FAQ
  • Customer Service
  • Contact Us
  • Your Story
  • Education
  • International
  • Press Center
  • Careers
  • Our Guarantee

Sign up for emails with the latest news, offers, and announcements from Epionce:

  • Dr. Carl
  • Returns
  • Shipping Policy
  • FAQ
  • Customer Service
  • Contact Us
  • Your Story
  • Education
  • International
  • Press Center
  • Careers
  • Our Guarantee

The U.S. Food and Drug Administration (FDA) defines cosmetics as "articles...applied to the human body...for cleansing, beautifying, promoting attractiveness, or altering the appearance." The majority of Epionce® products described on this website are intended to meet this definition. These Epionce® products and their associated statements have not been approved or evaluated by the FDA and are not intended to be drug products that diagnose, treat, cure, or prevent any disease or condition.

Epionce Ultra Shield SPF 50, Daily Shield Tinted SPF 50, Renewal Calming Cream, Purifying Wash and Purifying Spot Gel are considered over-the-counter drug products. They are formulated and marketed pursuant to the FDA’s governing regulations set forth at 21 C.F.R. Parts 352, 347, 333, respectively.

USA Canada United Kingdom Hong Kong Japan Poland The Netherlands

Privacy Policy | Legal | Sitemap

© 2019 Episciences, Inc.
All Rights Reserved Worldwide